← Back to Search

Behavioural Intervention

TrueRelief device for Rotator Cuff Tendinitis

N/A
Waitlist Available
Led By Vandana Sood, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up beginning of study (visit 1 - week 1), midpoint of study (visit 5 - week 2), end of study (visit 9 - week 3), 1-month post-treatment follow-up call (week 7-9)

Summary

This trial is testing if a new device, TrueRelief, can help improve shoulder pain for patients. The investigators think that patients with fewer medical problems will see the most improvement.

Eligible Conditions
  • Rotator Cuff Tendinitis
  • Shoulder Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~beginning of study (visit 1 - week 1), midpoint of study (visit 5 - week 2), end of study (visit 9 - week 3), 1-month post-treatment follow-up call (week 7-9)
This trial's timeline: 3 weeks for screening, Varies for treatment, and beginning of study (visit 1 - week 1), midpoint of study (visit 5 - week 2), end of study (visit 9 - week 3), 1-month post-treatment follow-up call (week 7-9) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in pain measurements in patients with Supraspinatus Tendonitis (SST).
Secondary study objectives
Change in perceived shoulder function as measured by QuickDASH Questionnaire in patients with Supraspinatus Tendonitis (SST).
Change in perceived shoulder function as measured by a Shoulder Rating Questionnaire in patients with Supraspinatus Tendonitis (SST).

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ExperimentalExperimental Treatment1 Intervention
Patients receive an experimental procedure using a TrueRelief device.
Group II: PlaceboPlacebo Group1 Intervention
Patients receive a placebo procedure using a sham TrueRelief device that looks and operates identically to the experimental TrueRelief device but will not emit any high frequency current.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TrueRelief device
2022
N/A
~140

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,081 Previous Clinical Trials
1,138,039 Total Patients Enrolled
TrueRelief, LLCUNKNOWN
1 Previous Clinical Trials
134 Total Patients Enrolled
Vandana Sood, MDPrincipal InvestigatorWeill Medical College of Cornell University
~0 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top